SB 273 IN

0likes☆Favorite🔕SubscribeShare

Became Law

Requires a health plan (which includes a policy of accident and sickness insurance, a health maintenance organization contract, the Medicaid risk based managed care program, and a state employee health plan) to provide coverage for biomarker testing for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee's disease or condition when biomarker testing is supported by medical and scientific evidence. Requires the office of Medicaid policy and planning to provide biomarker testing as a Medicaid program service, and to apply to the United States Department of Health and Human Services for approval of any waiver necessary under the federal Medicaid program for the purpose of providing biomarker testing. Provides that coverage is not required for biomarker testing for screening purposes. Provides that if a prior authorization requirement applies to biomarker testing, the health plan or a third party acting on behalf of the health plan must: (1) approve or deny a request for prior authorization; and (2) notify the covered individual of the approval or denial; in not more than five business days in the case of a nonurgent request or in not more than 48 hours in the case of an urgent request. Requires the office of the secretary of family and social services to report certain information to the budget committee on Medicaid reimbursement rates provided for biomarker testing.

• Ed Charbonneau Republican · author
• Vaneta Becker Republican · author
• Jean Leising Republican · author
• Brad Barrett Republican · sponsor

1. Jan 11, 2024 First reading: referred to Committee on Insurance and Financial Institutions · upper
2. Jan 11, 2024 Authored by Senators Charbonneau and Becker · upper
3. Jan 16, 2024 Senator Qaddoura added as coauthor · upper
4. Jan 18, 2024 Senator Leising added as third author · upper
5. Jan 18, 2024 Committee report: amend do pass adopted; reassigned to Committee on Appropriations · upper
6. Jan 22, 2024 Senator Bohacek added as coauthor · upper
7. Jan 23, 2024 Senator Bassler added as coauthor · upper
8. Jan 25, 2024 Senator Glick added as coauthor · upper
9. Feb 1, 2024 Senator Ford J.D. added as coauthor · upper
10. Feb 1, 2024 Senator Randolph added as coauthor · upper
11. Feb 1, 2024 Senator Yoder added as coauthor · upper
12. Feb 1, 2024 Committee report: amend do pass, adopted · upper
13. Feb 5, 2024 Second reading: ordered engrossed · upper
14. Feb 6, 2024 Third reading: passed; Roll Call 142: yeas 47, nays 1 · upper
15. Feb 6, 2024 House sponsor: Representative Barrett · upper
16. Feb 7, 2024 Referred to the House · upper
17. Feb 12, 2024 First reading: referred to Committee on Insurance · lower
18. Feb 13, 2024 Representative Clere added as cosponsor · lower
19. Feb 15, 2024 Representative Porter added as cosponsor · lower
20. Feb 15, 2024 Representative Lehman added as cosponsor · lower
21. Feb 15, 2024 Referred to the Committee on Ways and Means pursuant to House Rule 127 · lower
22. Feb 15, 2024 Committee report: do pass, adopted · lower
23. Feb 22, 2024 Committee report: do pass, adopted · lower
24. Feb 26, 2024 Second reading: ordered engrossed · lower
25. Feb 27, 2024 Third reading: passed; Roll Call 236: yeas 94, nays 0 · lower
26. Feb 28, 2024 Returned to the Senate without amendments · lower
27. Mar 4, 2024 Signed by the President Pro Tempore · upper
28. Mar 7, 2024 Signed by the Speaker · lower
29. Mar 8, 2024 Signed by the President of the Senate · upper
30. Mar 11, 2024 Signed by the Governor · executive
31. Mar 11, 2024 Public Law 37 · upper